Skip to main content

Table 4 Relation between xerostomia free survival and different variables (Log Rank test)

From: Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)

Variables

Free survival at 60 months (%)

Exp(B), CI 95%; p value

Age (years)

  

   < 58

89.7

 

   >58

68.4

0.460 (0.109-1.702); 0.160

Gender

  

   Male

82.0

 

   Female

80.0

1.676 (0.261-10.22); 0.601

Tumour localization

  

   OC + Or a

73.1

(avs.b) 2.166 (0.306-13.04); 0.524

   L + H b

100

(avs.c) 1.146 (0.281-4.712); 0.845

   N + U/M c

84.4

(bvs.c) 0.960 (0.101-9.101); 0.970

RT schedule

  

   Conventional

88.9

 

   Hyperfractionated

77.6

3.950 (0.955-13.88); 0.058

CMT

  

   Yes

87.2

 

   No

80

0.755 (0.188-2.926); 0.669

Surgery

  

   Yes

94.7

 

   No

76.8

3.910 (0.670-11.16); 0.161

Amifostine

  

   Yes

81.5

 

   No

85.5

0.617 (0.071-3.726); 0.510

β 24

  

   < 11.32

92.9

 

   > 11.32

73.9

0.224 (0.060-0.904); 0.035

  1. OC: oral cavity, Or: oropharynx, L: larynx, H: hypopharynx; N: nasopharynx,
  2. U/M: unknown origin/multiple, RT: radiotherapy, CMT: chemotherapy